Although Gankyrin has been proven to be involved in carcinogenesis and progression in various cancers, whether it contributes to cancer metastasis, angiogenesis and resistance to chemotherapy in CRC, still remains unclear. This evidence concerns the gene PSMD10 and colorectal carcinoma.